Tuttle Capital Management’s Isleworth Healthcare Acquisition Corporation Common stock ISLE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-40,697
Closed -$405K 114
2022
Q2
$405K Sell
40,697
-15,552
-28% -$154K 1.13% 39
2022
Q1
$557K Sell
56,249
-19,030
-25% -$187K 1.38% 30
2021
Q4
$741K Sell
75,279
-27,680
-27% -$272K 1.13% 38
2021
Q3
$1.01M Sell
102,959
-28,545
-22% -$278K 1.17% 33
2021
Q2
$1.29M Buy
131,504
+66,180
+101% +$646K 0.57% 56
2021
Q1
$633K Buy
+65,324
New +$631K 0.25% 100

Tuttle Capital Management's ISLE Position: Q3 2022 in Review

Tuttle Capital Management sold out of Isleworth Healthcare Acquisition Corporation Common stock (ISLE) in Q3 2022, closing a stake of 40,697 shares — an estimated $405K sold.

Tuttle Capital Management first reported a position in ISLE in Q1 2021 and held it in 6 quarters. The position peaked at $1.29M in Q2 2021. 0 funds tracked by Wall St. Rank hold ISLE as of Q3 2022.

  • Tuttle Capital Management reported no remaining Isleworth Healthcare Acquisition Corporation Common stock position as of Q3 2022 after selling out during the quarter.
  • Tuttle Capital Management sold 40,697 Isleworth Healthcare Acquisition Corporation Common stock shares in Q3 2022, an estimated $405K.
  • Tuttle Capital Management first reported a position in Isleworth Healthcare Acquisition Corporation Common stock in Q1 2021 and held it in 6 quarters.
  • Tuttle Capital Management's Isleworth Healthcare Acquisition Corporation Common stock position peaked at $1.29M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Isleworth Healthcare Acquisition Corporation Common stock as of Q3 2022.

Based on Tuttle Capital Management's 13F filing for Q3 2022, filed 11 Oct 2022.